Company · CIK 0001656634 · SIC 2836 — Biological Products, (No Diagnostic Substances)
Gritstone Oncology, Inc. · GRTS
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2019 MForm 4 → | Mar 6, 8:03 pm EST | Erin JonesSee Remarks | 10,000 | $0.345 | $3,450 | 10,000 | — | plan? late |
| Oct 2, 2018 CForm 4 → | Oct 3, 5:35 pm EDT | Redmile Group, LLC +110% Owner | 1,394,529 | — | — | 1,394,529 | — | plan? |
| Oct 2, 2018 CForm 4 → | Oct 2, 5:29 pm EDT | Thomas WoiwodeDirector, 10% Owner | 3,102,929 | — | — | 3,102,929 | — | plan? |
| Oct 2, 2018 CForm 4 → | Oct 2, 5:28 pm EDT | Versant Venture Capital V, L.P. +310% Owner | 3,102,929 | — | — | 3,102,929 | — | plan? |
| Oct 2, 2018 CForm 4 → | Oct 2, 5:26 pm EDT | Peter SvennilsonDirector, 10% Owner | 3,102,934 | — | — | 3,102,934 | — | plan? |
| Oct 2, 2018 CForm 4 → | Oct 2, 5:24 pm EDT | COLUMN GROUP II, LP +310% Owner | 3,102,934 | — | — | 3,102,934 | — | plan? |
| Oct 2, 2018 CForm 4 → | Oct 2, 5:23 pm EDT | Nicholas SimonDirector, 10% Owner | 2,234,112 | — | — | 2,567,445 | — | plan? |
| Oct 2, 2018 CForm 4 → | Oct 2, 5:20 pm EDT | Clarus Lifesciences III, L.P. +210% Owner | 2,234,112 | — | — | 2,567,445 | — | plan? |
| Sep 28, 2018 PForm 4 → | Oct 2, 5:23 pm EDT | Nicholas SimonDirector, 10% Owner | 333,333 | $15.00 | $4,999,995 | 333,333 | — | plan? |
| Sep 28, 2018 PForm 4 → | Oct 2, 5:20 pm EDT | Clarus Lifesciences III, L.P. +210% Owner | 333,333 | $15.00 | $4,999,995 | 333,333 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2019 MForm 4 → | Mar 6, 8:03 pm EST | Erin JonesSee Remarks | 10,000 | — | — | 47,971 | — | late |
| Oct 2, 2018 CForm 4 → | Oct 3, 5:35 pm EDT | Redmile Group, LLC +110% Owner | 1,394,529 | — | — | 0 | — | |
| Oct 2, 2018 CForm 4 → | Oct 2, 5:29 pm EDT | Thomas WoiwodeDirector, 10% Owner | 3,102,929 | — | — | 0 | — | |
| Oct 2, 2018 CForm 4 → | Oct 2, 5:28 pm EDT | Versant Venture Capital V, L.P. +310% Owner | 3,102,929 | — | — | 0 | — | |
| Oct 2, 2018 CForm 4 → | Oct 2, 5:26 pm EDT | Peter SvennilsonDirector, 10% Owner | 3,102,934 | — | — | 0 | — | |
| Oct 2, 2018 CForm 4 → | Oct 2, 5:24 pm EDT | COLUMN GROUP II, LP +310% Owner | 3,102,934 | — | — | 0 | — | |
| Oct 2, 2018 CForm 4 → | Oct 2, 5:23 pm EDT | Nicholas SimonDirector, 10% Owner | 2,234,112 | — | — | 0 | — | |
| Oct 2, 2018 CForm 4 → | Oct 2, 5:20 pm EDT | Clarus Lifesciences III, L.P. +210% Owner | 2,234,112 | — | — | 0 | — |